admin

Active Pharmaceutical Ingredient (API) is one of the important segments of the pharma business that makes up about 35% of the market. According to World Health Organization, API is any drug or mixture of drugs employed in a finished pharmaceutical product (or FPP) to provide pharmacological activity or to otherwise have direct action in the […]

The global increase in depression and anxiety cases continues to drive the demand for fluoxetine-based treatments across all age groups. Industry Overview Fluoxetine hydrochloride Fluoxetine is a Selective Serotonin Reuptake Inhibitor (SSRI) antidepressant that acts by preventing the reuptake of SSRI by neurons. It is classified as a prescription drug that comes in several forms

China has made itself the undisputed powerhouse in the Active Pharmaceutical Ingredient (API) market globally, redefining how pharmaceutical supply chains function. Around 20% of global API production and exports to 180 nations. The country’s massive production capabilities, cost benefits of 35-40% less than Western rivals, and more advanced quality control have made it the backbone

Industry Overview Europe’s active pharmaceutical ingredients (API) market was valued at $45.4 billion in 2024 and is projected to grow at a CAGR of 5.9% during the forecast period (2025-2035). The European API industry is among the most powerful and basic components of the global pharma ecosystem. As the fundamental ingredient of each pharma drug,

Imatinib Mesylate Market is driven by growing adoption of generic imatinib formulations across developing economies, improving drug accessibility and affordability. Industry Overview Imatinib mesylate market Imatinib mesylate, also known as a Tyrosine Kinase Inhibitor (TKI), is mainly indicated for the treatment of Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and Gastrointestinal Stromal Tumors (GIST).

Industry Overview United States Active Pharmaceutical Ingredients (API) market is undergoing a dynamic phase, marked by high growth opportunities balanced with geopolitical and economic concerns. The U.S. API market stood at around $37.4 billion in 2024 and is anticipated to grow to $72.8 billion by 2035, at a 7.1% CAGR during the forecast period. The

Growing global allergy prevalence, particularly allergic rhinitis and chronic urticaria, is significantly driving the demand for second-generation antihistamines. Industry Overview Desloratadine Desloratadine is an antihistamine that is used to obtain relief from allergic symptoms like sneezing, rhinorrhea, and rashes resulting from chronic reactions. The expansion in the global market for desloratadine is fueled by drivers

Rising consumer shift toward preventive healthcare and vitamin-based therapies is boosting demand for benfotiamine. Industry Overview Benfotiamine The growth trend is influenced by the increasing application of this technology in pharmaceuticals, nutraceuticals, and functional food markets. The global benfotiamine market is experiencing a revival, driven by growing awareness of diabetic neuropathy, rising geriatric population, and

Hormone receptor-positive breast cancer, expanding generic drug access, and emerging applications in prostate cancer are propelling the global Anastrozole market forward. Industry Overview Anastrozole This expansion is largely fueled by the growing incidence of hormone receptor-positive breast cancer, mainly among postmenopausal women. Anastrozole, an aromatase inhibitor, is critical in the treatment of this type of

Increasing investments in mental health infrastructure, particularly in developing economies, are fueling the expansion of aripiprazole availability and accessibility. Industry Overview Aripiprazole This growth is driven by increasing need for efficient treatments for schizophrenia, bipolar disorder, and major depressive disorder, among others. Aripiprazole is an atypical antipsychotic that operates as a partial agonist of the